Phillips, Tiffany R.
Medland, Nicholas
Chow, Eric P. F.
Maddaford, Kate
Wigan, Rebecca
Fairley, Christopher K.
Bilardi, Jade E.
Ong, Jason J.
Funding for this research was provided by:
Gilead Pharmaceuticals
Article History
Received: 4 March 2021
Accepted: 4 February 2022
First Online: 3 March 2022
Declarations
:
: Ethical approval was obtained from the Alfred Hospital Ethics Committee, Melbourne, Australia (project number: 222/19) on the 30th April 2019. Written informed consent was obtained for all participants. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: NM, EPFC and JJO have received a research grant from Gilead Pharmaceuticals to conduct this investigator-initiated study. EPFC is supported by an Australian National Health and Medical Research Council (NHMRC) Emerging Leadership Investigator Grant (GNT1172873). CKF is supported by NHMRC Investigator grant (GNT1172900). JEB is supported by an Australian Research Council Discovery Early Career Researcher Award (DECRA) Fellowship (DE200100049). JJO is supported by an Australian NHRMC Early Career Fellowship (GNT1104781). All other authors have no conflicts of interest to declare.